Edlin BR - Search Results

1

Access to treatment for hepatitis C virus infection: time to put patients first.

Edlin BR. Edlin BR. Lancet Infect Dis. 2016 Sep;16(9):e196-e201. doi: 10.1016/S1473-3099(16)30005-6. Epub 2016 Jul 13. Lancet Infect Dis. 2016. PMID: 27421993 Review.

2

Can hepatitis C be eradicated in the United States?

Edlin BR, Winkelstein ER. Edlin BR, et al. Antiviral Res. 2014 Oct;110:79-93. doi: 10.1016/j.antiviral.2014.07.015. Epub 2014 Aug 7. Antiviral Res. 2014. PMID: 25110202

3

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA. Edlin BR, et al. Clin Infect Dis. 2005 Apr 15;40 Suppl 5(Suppl 5):S276-85. doi: 10.1086/427441. Clin Infect Dis. 2005. PMID: 15768335 Free PMC article. Review.

4

Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations.

Moreno GA, Wang A, Sánchez González Y, Díaz Espinosa O, Vania DK, Edlin BR, Brookmeyer R. Moreno GA, et al. Among authors: edlin br. Value Health. 2017 Jun;20(6):736-744. doi: 10.1016/j.jval.2017.01.015. Epub 2017 Feb 23. Value Health. 2017. PMID: 28577690 Free article.

5

Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients.

Canchis PW, Yee HT, Fiel MI, Dieterich DT, Liu RC, Chiriboga L, Jacobson IM, Edlin BR, Talal AH. Canchis PW, et al. Among authors: edlin br. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1125-31. doi: 10.1097/01.qai.0000131937.52106.92. J Acquir Immune Defic Syndr. 2004. PMID: 15319671

6

Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.

Hofmeister MG, Rosenthal EM, Barker LK, Rosenberg ES, Barranco MA, Hall EW, Edlin BR, Mermin J, Ward JW, Ryerson AB. Hofmeister MG, et al. Among authors: edlin br. Hepatology. 2019 Mar;69(3):1020-1031. doi: 10.1002/hep.30297. Epub 2018 Nov 6. Hepatology. 2019. PMID: 30398671 Free PMC article. Review.

7

Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Edlin BR, et al. Hepatology. 2015 Nov;62(5):1353-63. doi: 10.1002/hep.27978. Epub 2015 Aug 25. Hepatology. 2015. PMID: 26171595 Free PMC article.

8

Hepatitis C screening: getting it right.

Edlin BR. Edlin BR. Hepatology. 2013 Apr;57(4):1644-50. doi: 10.1002/hep.26194. Epub 2012 Dec 24. Hepatology. 2013. PMID: 23239521 Free PMC article.

9

Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program.

Eckhardt BJ, Scherer M, Winkelstein E, Marks K, Edlin BR. Eckhardt BJ, et al. Among authors: edlin br. Open Forum Infect Dis. 2018 Mar 6;5(4):ofy048. doi: 10.1093/ofid/ofy048. eCollection 2018 Apr. Open Forum Infect Dis. 2018. PMID: 29644246 Free PMC article.

10

Hepatitis D Viremia Among Injection Drug Users in San Francisco.

Mahale P, Aka PV, Chen X, Liu P, Fram BJ, Wang AS, Simenel S, Tseng FC, Chen S, Edlin BR, Glenn JS, O'Brien TR. Mahale P, et al. Among authors: edlin br. J Infect Dis. 2018 May 25;217(12):1902-1906. doi: 10.1093/infdis/jiy157. J Infect Dis. 2018. PMID: 29800369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page